Literature DB >> 8131214

In vitro modulation of T-cell surface molecules by iron.

M Santos1, M de Sousa.   

Abstract

Iron and zinc are known to have immunomodulatory functions. In the present work, iron (FeC6H5O7) and zinc (ZnCl2) were tested in comparison to nickel (NiCl2) and cobalt (CoCl2) for their effect on six different surface molecules known to be involved in recognition and activation processes, namely CD4, CD2, CD3, CD8, HLA-ABC, and HLA-DR. Iron was seen to down-modulate expression of the CD4 and the CD2 molecules on the surface of T-lymphocytes, as indicated by a decrease in the mean fluorescence intensity measured by FACS analysis. None of the other T-cell molecules tested were significantly affected. In addition, the iron-mediated CD4 down-modulation reached its lowest level by 12 hr, at which time a striking decrease in the percentage of CD4+, but not CD8+, cells was observed. This decrease was followed by a gradual recovery starting at 18 hr and reaching its highest level at 48 hr. When cells were treated with other metal salts, none of those effects were observed. The present results suggest that iron may play a regulatory role in processes of T-cell recognition and T-cell activation by selectively down-modulating T-cell molecules known to be involved in these processes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8131214     DOI: 10.1006/cimm.1994.1094

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  5 in total

1.  Impact of hemochromatosis gene (HFE) mutations on epithelial ovarian cancer risk and prognosis.

Authors:  Philippe O Gannon; Sanae Medelci; Cécile Le Page; Martin Beaulieu; Diane M Provencher; Anne-Marie Mes-Masson; Manuela M Santos
Journal:  Int J Cancer       Date:  2011-05-15       Impact factor: 7.396

2.  Cobalt-chromium-molybdenum but not titanium-6aluminium-4vanadium alloy discs inhibit human T cell activation in vitro.

Authors:  C Faleiro; I Godinho; U Reus; M de Sousa
Journal:  Biometals       Date:  1996-10       Impact factor: 2.949

3.  The pharmacokinetics and pharmacodynamics of iron preparations.

Authors:  Peter Geisser; Susanna Burckhardt
Journal:  Pharmaceutics       Date:  2011-01-04       Impact factor: 6.321

Review 4.  The hemochromatosis protein HFE 20 years later: An emerging role in antigen presentation and in the immune system.

Authors:  Alexandre Reuben; Jacqueline W Chung; Réjean Lapointe; Manuela M Santos
Journal:  Immun Inflamm Dis       Date:  2017-04-19

Review 5.  Altered Iron Metabolism and Impact in Cancer Biology, Metastasis, and Immunology.

Authors:  Rikki A M Brown; Kirsty L Richardson; Tasnuva D Kabir; Debbie Trinder; Ruth Ganss; Peter J Leedman
Journal:  Front Oncol       Date:  2020-04-09       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.